Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi Center, International, Open Label Study of the Use of Magseed Pro(R) Markers and Sentimag(R) Gen3 to Localize Breast Lesions and Suspicious/Biopsy-proven Positive Lymph Nodes in Breast Cancer Patients

NCT05142787 is registered in ClinicalTrials.gov with Endomagnetics Ltd. as lead sponsor.

NCT NCT05142787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi Center, International, Open Label Study of the Use of Magseed Pro(R) Markers and Sentimag(R) Gen3 to Localize Breast Lesions and Suspicious/Biopsy-proven Positive Lymph Nodes in Breast Cancer Patients
Lead sponsor
Endomagnetics Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
March 2, 2023
Completion date
June 30, 2028
Enrollment
224 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer